Rite Aid and certain executives were hit with a securities class action Wednesday in Pennsylvania Eastern District Court concerning pharmacy benefit management services offered through the company's subsidiary Elixir. The complaint, brought by Pomerantz LLP and other counsel, accuses the defendants of failing to disclose that the company was subject to a $252.2 million impairment-of-goodwill charge due to a decrease in sales. Counsel have not yet appeared for the defendants. The case is 2:22-cv-04201, Page v. Rite Aid Corporation et al.

This suit was surfaced by Law.com Radar, a source for high-speed legal news and litigation updates personalized to your practice. Law.com Radar publishes daily updates on just-filed federal cases like this one. Click here to get started and be first to know about new suits in your region, practice area or client sector. Read the complaint here: